Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Summary report on the twentieth meeting of the Regional Programme Review Group and national neglected tropical diseases programme managers, virtual meeting, 23–25 May 2022

WHO Regional Office for the Eastern Mediterranean . World Health Organization. 2022;
Download PDF
Publication

Implementation approaches for leprosy prevention with single-dose rifampicin: A support tool for decision making.

Ellen F, Tielens K, Fenenga C, et al. PLoS neglected tropical diseases. 2022; 16 (10) : e0010792.
Download PDF
Publication

Os impactos na vigilância das doenças tropicais negligenciadas durante a pandemia da COVID-19

Neta MCMFG, Vieira AA, Ribeiro ÁDF, et al. Brazilian Journal of Development. 2022; 8 (10) : 66927-66942.
Download PDF
Publication

Conhecimento, atitude e prática de enfermeiros acerca da prevenção e tratamento da hanseníase na atenção primária: nota prévia

Dias SM, Barbosa AC, Carrijo MVN. Research, Society and Development. 2022;
Download PDF
Other

GPZL & Infolep Factsheets

Publication

Factsheet on SDR-PEP: The latest research on single-dose rifampicin post-exposure prophylaxis

Global Partnership for Zero Leprosy , Infolep , ILEP Technical Commission . 2022;
Download PDF
Publication

Prevalence and risk factors for grade 2 disability among newly diagnosed leprosy in children and adolescents: a record-based analysis from India

Upputuri B, Vulchi N, Singh R, et al. Lepra. Leprosy Review. 2022; 93 (1) : 79-88.
Download PDF
Publication

Territory, neglected diseases and the action of community and endemic combat agents

Soledad Márdero Garcí G, Amorim de Souza E, de Araújo V, et al. RSP. Revista de Saúde Pública. 2022;
Download PDF
Publication

LepVax as a Promising Specific Vaccine for Leprosy: A Narrative Review

Adnan ML. Cambridge Medicine Journal. Cambridge Medicine Journal. 2022;
Download PDF
Publication

Population-wide active case finding and prevention for tuberculosis and leprosy elimination in Kiribati: the PEARL study protocol.

Coleman M, Hill J, Timeon E, et al. BMJ open. 2022; 12 (4) : e055295.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 21
  • Next page ››
Subscribe to Prevention of disease

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD